Clinical Trial Update: A 72-week Randomized Clinical Trial Comparing the Safety and Efficacy of Three Initial Antiretroviral Regimens -GPO-VIR S (d4T/3TC/NVP) for 24 Weeks Followed by GPO-VIR Z (AZT/3TC/NVP) vs GPO-VIR Z vs TDF/FTC/NVP [Phase 3]

View source ↗

Summary

Phase 3 randomized trial comparing three initial antiretroviral regimens in HIV infection, evaluating safety and efficacy with regimens including GPO-VIR S, GPO…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• Lamivudine (3TC) (lamivudine)
• Stavudine (d4T) (stavudine)
• Zidovudine (AZT) (Zidovudine)
• emtricitabine (FTC) (emtricitabine)
• nevirapine (NVP) (nevirapine)
• tenofovir disoproxil fumarate (TDF) (tenofovir disoproxil fumarate)

Snippet

Sponsor: SEARCH Research Foundation | Conditions: HIV Infections | Phase 3 | Status: COMPLETED